Thompson Siegel & Walmsley LLC Inogen Inc Transaction History
Thompson Siegel & Walmsley LLC
- $6.19 Billion
- Q3 2025
A detailed history of Thompson Siegel & Walmsley LLC transactions in Inogen Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 130,930 shares of INGN stock, worth $903,417. This represents 0.02% of its overall portfolio holdings.
Number of Shares
130,930
Previous 101,613
28.85%
Holding current value
$903,417
Previous $714,000
49.86%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding INGN
# of Institutions
142Shares Held
20.3MCall Options Held
21.7KPut Options Held
10K-
Black Rock Inc. New York, NY1.63MShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$9.87 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$7.36 Million0.02% of portfolio
-
Camber Capital Management LP Boston, MA975KShares$6.73 Million0.67% of portfolio
-
Armistice Capital, LLC New York, NY864KShares$5.96 Million0.11% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $158M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...